CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 54 filers reported holding CARDIFF ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,400 | +64110.5% | 17,554 | +67415.4% | 0.00% | – |
| Q2 2023 | $38 | – | 26 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 26 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 26 | -99.9% | 0.00% | – |
| Q1 2022 | $44,000 | -62.7% | 17,887 | -9.4% | 0.00% | – |
| Q4 2021 | $118,000 | -9.2% | 19,733 | +1.4% | 0.00% | – |
| Q3 2021 | $130,000 | +7.4% | 19,456 | +7.6% | 0.00% | – |
| Q2 2021 | $121,000 | +245.7% | 18,078 | +384.0% | 0.00% | – |
| Q1 2021 | $35,000 | -2.8% | 3,735 | +86.7% | 0.00% | – |
| Q4 2020 | $36,000 | – | 2,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 2,522,083 | $15,158,000 | 12.39% |
| Octagon Capital Advisors LP | 982,753 | $5,906,000 | 1.15% |
| Altium Capital Management LP | 337,000 | $2,025,000 | 0.56% |
| ACT CAPITAL MANAGEMENT, LLC | 102,500 | $616,000 | 0.44% |
| Eventide Asset Management | 1,670,399 | $10,039,000 | 0.13% |
| Artal Group S.A. | 750,000 | $4,508,000 | 0.12% |
| Aquatic Capital Management LLC | 8,000 | $48,000 | 0.09% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 17,300 | $104,000 | 0.06% |
| Anson Funds Management LP | 69,381 | $417,000 | 0.04% |
| KENNEDY CAPITAL MANAGEMENT LLC | 170,447 | $1,024,000 | 0.02% |